Stem Cell

Healio has compiled a list of its most-read nephrology care news in 2023.

Treatment with stem cells may be among the considerations in patients with ocular surface disease who have not responded to traditional therapy, according to a speaker at the Twin Cities Ocular Surface Disease Symposium.

Bioengineering company Ossium Health, which is developing the first bank of bone marrow collected from organ donors, has partnered with the National Marrow Donor Program/Be The Match to increase access to lifesaving bone marrow.

Intra-articular injections of autologous adipose-derived stem cells or adipose-derived stromal vascular fraction significantly improve pain and function in knee osteoarthritis, according to data published in Arthritis Research & Therapy.

Craniosynostosis — the premature joining of bones in an infant’s skull — may be caused by an abnormal excess of a previously unknown type of bone-forming stem cell, according to findings from a preclinical study reported in Nature.

Younger patients with diverse gut microbiota prior to allogeneic hematopoietic stem cell transplantation had a significantly lower risk for death following the procedure than those with low diversity, according to study results.

UC San Diego researcher Catriona Jamieson, MD, PhD, likes to think of it as a “literal cancer moonshot.”

A man has remained in treatment-free HIV remission for nearly 2 years after receiving a stem-cell transplant to treat a rare and aggressive form of leukemia, researchers reported Wednesday.

Eterna Therapeutics Inc. announced it has entered into an exclusive option and license agreement with Lineage Cell Therapeutics Inc. to create novel induced hypoimmune pluripotent stem cell lines for use in cell transplant therapies.

Vedolizumab showed greater efficacy than placebo when added to standard prophylaxis for prevention of lower gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, according to a study.